Recurrent B-Cell Non-Hodgkin Lymphoma

Explore clinical trials studying Recurrent B-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

25 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Recurrent B-Cell Non-Hodgkin Lymphoma trial results

Completed

NCT02950220

Conditions: B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +46 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

Completed

NCT01897012

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +36 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Completed

NCT01729806

Conditions: CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

City of Hope South Pasadena South Pasadena, California, United States

Completed

NCT00764517

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States

Completed

NCT02992223

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Not specified